| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |